Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan
Children's Healthcare of Atlanta-Egleston, Atlanta, Georgia, United States
University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Columbia University Irving Medical Center, New York, New York, United States
Ain Shams University Hospital, Cairo, EL Abassia, Egypt
Hopital FOCH, Suresnes, Ile-de-France, France
Rabin Medical Center, Petach Tikva, Israel
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
BC Children's Hospital - Department of Anesthesia, Vancouver, British Columbia, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.